125 related articles for article (PubMed ID: 30180967)
1. Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats.
Bai W; Zhang C; Chen H
Gene; 2018 Oct; 675():208-216. PubMed ID: 30180967
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.
Gao H; Wen JJ; Hu JL; Nie QX; Chen HH; Xiong T; Nie SP; Xie MY
Carbohydr Polym; 2018 Dec; 201():624-633. PubMed ID: 30241862
[TBL] [Abstract][Full Text] [Related]
3. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
[TBL] [Abstract][Full Text] [Related]
4. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
Ma C; Yu H; Xiao Y; Wang H
Pharm Biol; 2017 Dec; 55(1):2170-2177. PubMed ID: 29110587
[TBL] [Abstract][Full Text] [Related]
5. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
Wang Q; Wu X; Shi F; Liu Y
Biomed Pharmacother; 2019 Jan; 109():744-750. PubMed ID: 30551527
[TBL] [Abstract][Full Text] [Related]
7. Preparation of a Momordica charantia L. polysaccharide‑chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.
Zhang C; Huang M; Hong R; Chen H
Int J Biol Macromol; 2019 Feb; 122():619-627. PubMed ID: 30391593
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.
Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH
Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.
Ahmed I; Adeghate E; Cummings E; Sharma AK; Singh J
Mol Cell Biochem; 2004 Jun; 261(1-2):63-70. PubMed ID: 15362486
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice.
Xu X; Shan B; Liao CH; Xie JH; Wen PW; Shi JY
Int J Biol Macromol; 2015 Nov; 81():538-43. PubMed ID: 26318666
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Notch signaling and angiogenesis via an isolated polysaccharide from Momordica charantia in diabetic rats.
Sajadimajd S; Mohammadi B; Bahrami G; Madani SH; Hatami R; Miraghaee SS
J Food Biochem; 2022 Feb; 46(2):e14033. PubMed ID: 34964144
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of selenylated polysaccharides from Momordica charantia L. and its hypoglycemic activity in streptozotocin-induced diabetic mice.
Ru Y; Liu K; Kong X; Li X; Shi X; Chen H
Int J Biol Macromol; 2020 Jun; 152():295-304. PubMed ID: 32112833
[TBL] [Abstract][Full Text] [Related]
13. [The hypoglycemic effects of crude polysaccharides extract from Momordica charantia in mice].
Zheng ZX; Teng JY; Liu JY; Qiu JH; Ouyang H; Xue C
Wei Sheng Yan Jiu; 2005 May; 34(3):361-3. PubMed ID: 16111053
[TBL] [Abstract][Full Text] [Related]
14. Momordica charantia reverses type II diabetes in rat.
Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S
J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956
[TBL] [Abstract][Full Text] [Related]
15. Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats.
Zhu Y; Bai J; Zhang Y; Xiao X; Dong Y
Int J Food Sci Nutr; 2016 Sep; 67(6):686-95. PubMed ID: 27352776
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Treatment Efficacy of Essential Oil Isolated from Seeds of Momordica charantia in Streptozotocin-Induced Diabetes Mellitus.
Mariammal BGV; Devarajan DW; Jerrin R; Viswanathan S; Siddikuzzaman ; Gopal R
Recent Pat Biotechnol; 2021; 15(4):316-331. PubMed ID: 34515016
[TBL] [Abstract][Full Text] [Related]
17. Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats.
Raish M; Ahmad A; Jan BL; Alkharfy KM; Ansari MA; Mohsin K; Jenoobi FA; Al-Mohizea A
Int J Biol Macromol; 2016 Oct; 91():394-9. PubMed ID: 27238589
[TBL] [Abstract][Full Text] [Related]
18. Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
Hafizur RM; Kabir N; Chishti S
Nat Prod Res; 2011 Feb; 25(4):353-67. PubMed ID: 21328131
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats.
Jiao Y; Wang X; Jiang X; Kong F; Wang S; Yan C
J Ethnopharmacol; 2017 Mar; 199():119-127. PubMed ID: 28163112
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic activities of a cucurbitane‑type triterpenoid compound from Momordica charantia in alloxan‑induced diabetic mice.
Jiang B; Ji M; Liu W; Chen L; Cai Z; Zhao Y; Bi X
Mol Med Rep; 2016 Nov; 14(5):4865-4872. PubMed ID: 27748816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
